A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

Arthritis Research and Therapy

Volumn 14, Issue 5, 2012, Pages

  Ohta, Hiroyoshi ^a   Oka, Hiroshi ^b   Usui, Chie ^c   Ohkura, Masayuki ^a   Suzuki, Makoto ^a   Nishioka, Kusuki ^d  

^a PFIZER INC   (United States)

^b TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; PREGABALIN; 4 AMINOBUTYRIC ACID; ANALGESIC AGENT;

ABNORMAL SENSATION; ADULT; AGED; ARTICLE; BLURRED VISION; BREAST CANCER; CHRONIC DISEASE; CONSTIPATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL ASSESSMENT; HAMILTON ANXIETY SCALE; HEADACHE; HEALTH STATUS; HUMAN; INSOMNIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCULOSKELETAL STIFFNESS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT GLOBAL IMPRESSION OF CHANGE; PERIPHERAL EDEMA; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOPHARYNGITIS; SCORING SYSTEM; SIDE EFFECT; SLEEP TIME; SOMNOLENCE; SUICIDAL IDEATION; TREATMENT OUTCOME; UNCONSCIOUSNESS; VIRAL GASTROENTERITIS; VISUAL ANALOG SCALE; WEIGHT GAIN; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DOSE RESPONSE; INCIDENCE; JAPAN; MIDDLE AGED; PAIN MEASUREMENT; SLEEP DISORDERS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 84867287198     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4056     Document Type: Article

References (35)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172. 10.1002/art.1780330203, 2306288.
2. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003, 17:685-701. 10.1016/S1521-6942(03)00035-4, 12849719.
3. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005, 75:6-21.
4. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA. Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 2009, 36:2318-2329. 10.3899/jrheum.090367, 3419373, 19820221.
5. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610.
6. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 2008, 59:952-960. 10.1002/art.23826, 18576290.
7. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19-28. 10.1002/art.1780380104, 7818567.
8. Matsumoto M. Epidemiology of fibromyalgia. Pharma Medica 2006, 24:35-39. Japanese.
9. Nishioka K. Research platform for fibromyalgia in Japan. Arthritis Res Ther 2012, 14(Suppl 1):O5.
10. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U, Martin SA, Barrett JA, Haig G. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008, 9:792-805. 10.1016/j.jpain.2008.03.013, 18524684.
11. Crofford LJ, Mease PJ, Simpson SL, Young JP, Martin SA, Haig GM, Sharma U. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008, 136:419-431. 10.1016/j.pain.2008.02.027, 18400400.
12. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP, LaMoreaux LK, Martin SA, Sharma U. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005, 52:1264-1273. 10.1002/art.20983, 15818684.
13. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Martin SA, Sharma U. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008, 35:502-514.
14. Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol 2011, 38:2643-2652. 10.3899/jrheum.110569, 21965636.
15. Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 2006, 103:17537-17542. 10.1073/pnas.0409066103, 1859964, 17088553.
16. Pfizer Inc LYRICA prescribing information. Pfizer Inc., http://labeling.pfizer.com/ShowLabeling.aspx?id=561
17. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008, 9:105-121. 10.1016/j.jpain.2007.09.005, 18055266.
18. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-158. 10.1016/S0304-3959(01)00349-9, 11690728.
19. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991, 18:728-733.
20. Osada K, Oka H, Isomura T, Nakamura I, Tominaga K, Takahashi S, Kojima A, Nishioka K. Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity. Int J Rheum Dis 2011, 14:74-80. 10.1111/j.1756-185X.2010.01585.x, 21303485.
21. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
22. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale Manual 1994, London: NFER Nelson.
23. Cappelleri JC, Bushmakin AG, McDermott AM, Sadosky AB, Petrie CD, Martin S. Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Health Qual Life Outcomes 2009, 7:54. 10.1186/1477-7525-7-54, 2706811, 19534799.
24. Hays RD, Stewart AL. Sleep measures. Measuring Functioning and Well-Being 1992, 235-239. Durham, NC: Duke University Press, Stewart AL, Ware JE Jr.
25. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005, 23:S154-162.
26. Harding SM. Sleep in fibromyalgia patients: subjective and objective findings. Am J Med Sci 1998, 315:367-376. 10.1097/00000441-199806000-00005, 9638893.
27. Moldofsky H. The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome. Rheum Dis Clin North Am 2009, 35:275-283. 10.1016/j.rdc.2009.05.008, 19647142.
28. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 2008, 59:961-967. 10.1002/art.23828, 18576297.
29. Garcia-Borreguero D, Larrosa O, Williams AM, Albares J, Pascual M, Palacios JC, Fernandez C. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology 2010, 74:1897-1904. 10.1212/WNL.0b013e3181e1ce73, 20427750.
30. Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003, 60:1274-1283. 10.1212/01.WNL.0000055433.55136.55, 12707429.
31. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006, 67:1792-1800. 10.1212/01.wnl.0000244422.45278.ff, 17130411.
32. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115:254-263. 10.1016/j.pain.2005.02.032, 15911152.
33. van Seventer R, Feister HA, Young JP, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin 2006, 22:375-384. 10.1185/030079906X80404, 16466610.
34. Roth T, Lankford DA, Bhadra P, Whalen E, Resnick EM. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study. Arthritis Care Res (Hoboken) 2012, 64:597-606.
35. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009, CD007076.